Multiple Myeloma: Risk Stratification and Toxicity Management
Presented by Tiffany Richards, PhD, ANP, AOCNP®, and Hans Lee, MD
The University of Texas MD Anderson Cancer Center, Houston, Texas
Presenters’ disclosures of conflicts of interest are found at the end of this article.
J Adv Pract Oncol 2018;9(3):329–335 |
© 2018 Harborside™
The treatment landscape for multiple myeloma is rapidly changing. At JADPRO Live 2017, presenters brought advanced practitioners up to date on the newest approaches to the management of this disease, as well as what to be aware of when treating common side effects.
For access to the full length article, please sign in